A detailed history of Dudley & Shanley, Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Dudley & Shanley, Inc. holds 16,200 shares of OCUL stock, worth $137,700. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,200
Holding current value
$137,700
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$4.2 - $8.69 $68,040 - $140,778
16,200 New
16,200 $110,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Dudley & Shanley, Inc. Portfolio

Follow Dudley & Shanley, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dudley & Shanley, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dudley & Shanley, Inc. with notifications on news.